Marco Demaria

Full Professor in Cellular Aging, Director Research Institute Mechanisms of Health, Aging and Disease, Editor in Chief Aging-US, Biotech founder and consultant

About

I am a Full Professor of Cellular Ageing and Senescence at the University Medical Center Groningen (UMCG), University of Groningen, the Netherlands, where I lead an internationally recognized research group investigating the molecular mechanisms of ageing, cellular senescence, and age-related diseases. My research focuses on identifying therapeutic strategies to improve healthspan, with particular expertise in senotherapeutics, inflammation, cancer biology, immune regulation, and drug discovery. I have extensive experience in preclinical research, translational medicine, biomarker development, and the evaluation of emerging therapeutic approaches targeting ageing-related pathways. In addition to my academic research, I have substantial experience in scientific leadership, international collaborations, editorial management, and advising biotechnology and pharmaceutical companies. I serve as Editor-in-Chief of *Aging-US* and have held leadership positions in international scientific organizations and research institutes. I have authored over 100 scientific publications, with more than 30,000 citations, and have been recognized as a Highly Cited Researcher. I bring a combination of deep scientific expertise, strategic insight, and practical experience in evaluating innovative technologies, therapeutic pipelines, and opportunities in the biotechnology, pharmaceutical, and longevity sectors.

Publications

A consensus roadmap from the SENESCENCE2030 network towards precision senescence medicine
Nature Aging
2026
Cellular senescence: six decades of discovery and reinvention
The EMBO Journal
2026
Disruption of CDK4/6–RARα–NF-κB axis attenuates senescence-associated inflammation and improves function during aging and following chemotherapy
Nature Aging
2026
Integrative Omics Reveal Female‐Specific Benefits of p16 + Cell Clearance in Aging Mice
Advanced Science
2025
SenFlag gene signature identifies senescent cells in mouse and human tissues through a conserved core transcriptional program
The EMBO Journal
2026
Advancing senescence translation through the Senotherapeutics Biomarker Consortium
Nature Aging
2026
Cancer treatments accelerate ageing
Nature Reviews Cancer
2025
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer
Unknown Venue
2024
Converting cell death into senescence by PARP1 inhibition improves recovery from acute oxidative injury
Nature Aging
2024
The senescence-associated secretory phenotype and its physiological and pathological implications
Nature Reviews Molecular Cell Biology
2024
Guidelines for minimal information on cellular senescence experimentation in vivo
Cell
2024
Author response for "High dietary protein and fat contents exacerbate hepatic senescence and SASP in mice"
Unknown Venue
2021
Circulating monocytes expressing senescence‐associated features are enriched in COVID ‐19 patients with severe disease
Aging Cell
2023
Senescence and cancer — role and therapeutic opportunities
Nature Reviews Clinical Oncology
2022
Pharmacological CDK4/6 inhibition reveals a p53‐dependent senescent state with restricted toxicity
The EMBO Journal
2022
Enhanced extrinsic apoptosis of therapy-induced senescent cancer cells using a death receptor 5 (DR5) selective agonist
Cancer Letters
2022
Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression
Nature Communications
2022
Identification of distinct and age‐dependent p16High microglia subtypes
Aging Cell
2021
Physiological hypoxia restrains the senescence-associated secretory phenotype via AMPK-mediated mTOR suppression
Molecular Cell
2021
To breathe or not to breathe: Understanding how oxygen sensing contributes to age-related phenotypes
Ageing Research Reviews
2021
Algorithmic assessment of cellular senescence in experimental and clinical specimens
Nature Protocols
2021
Senescent Cells in Cancer Therapy: Friends or Foes?
Trends in Cancer
2020
A Senescence-Centric View of Aging: Implications for Longevity and Disease
Trends in Cell Biology
2020
Prolonged hypoxia delays aging and preserves functionality of human amniotic fluid stem cells
Mechanisms of Ageing and Development
2020
Cellular Senescence: Defining a Path Forward
Cell
2019
Hallmarks of Cellular Senescence
Trends in Cell Biology
2018
The effects of graded caloric restriction: XII . Comparison of mouse to human impact on cellular senescence in the colon
Aging Cell
2018
Unmasking Transcriptional Heterogeneity in Senescent Cells
Current Biology
2017
Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment
Nature Medicine
2017
Data from Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
Unknown Venue
2023
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Nature Medicine
2015
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Developmental Cell
2014

Education

University of California, Berkeley

Certificate, General Nutrition / January, 2014

Università degli Studi di Torino

Master of Science (MS), Molecular Biotechnology / January, 2007

Università degli Studi di Torino

Doctor of Philosophy (Ph.D.), Molecular Medicine / January, 2011

Università degli Studi di Torino

Bachelor of Science (BS), Molecular Biotechnology / January, 2005

Experience

ERIBA - European Research Institute for the Biology of Ageing

Full Professor / May, 2024 — Present

Associate Professor / July, 2020 — September, 2024

Assistant Professor / August, 2015 — June, 2020

Cellular senescence and age-related pathology

UMCG

Director, Mechanisms of Health, Ageing and Disease (MoHAD) Institute / July, 2023 — Present

Aging (Aging-US)

Editor in Chief / January, 2025 — Present

Phaedon Institute

Chair Scientific Advisory Board / March, 2023 — Present

International Cell Senescence Association (ICSA)

President / January, 2022 — January, 2026

npj aging

Editor In Chief / November, 2022 — December, 2024

Cleara Biotech

Co-Founder / July, 2018 — July, 2023

Aging Cell

Editorial Board Member / January, 2019 — November, 2022

PLOS ONE

Academic Editor / July, 2018 — July, 2020

Nature Research (Publishing)

Editorial Board Scientific Reports / April, 2016 — January, 2019

GLG (Gerson Lehrman Group)

Independent Consultant / October, 2016 — November, 2017

Helping healthcare firms to identify potential new strategies to extend healthy aging

Deep Knowledge Life Sciences

Scientific Advisor / December, 2016 — September, 2017

Advising for potential investments in early-stage biotech companies aimed at tackling aging and age-related diseases.

Buck Institute for Age Research

Post-doctoral Fellow / January, 2012 — July, 2015

Non-cell autonomous effects of senescence in cancer and wound healing

UNITY Biotechnology

Consultant / April, 2012 — June, 2015

Discovery and pre-clinical study of senolytic agents

Journal of Postdoctoral research

Contributing Editor / January, 2014 — May, 2015

Editor, reviewer and contributor of articles, reviews and commentaries

University of Torino

PhD student / January, 2008 — December, 2011

Transcriptional regulation in cancer metabolism

Medical University of Vienna

Internship / August, 2007 — October, 2007

Co-operation of transcription factors during tumorigenesis

University of Turin

Internship / April, 2004 — July, 2007

Gene expression profiling in cancer

Join Marco on NotedSource!
Join Now

At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.

For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.

For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.

Expert Institutions
NotedSource has experts from Stanford University
Expert institutions using NotedSource include Oxfort University
Experts from McGill have used NotedSource to share their expertise
University of Chicago experts have used NotedSource
MIT researchers have used NotedSource
Proudly trusted by
Microsoft uses NotedSource for academic partnerships
Johnson & Johnson academic research projects on NotedSource
ProQuest (Clarivate) uses NotedSource as their industry academia platform
Slamom consulting engages academics for research collaboration on NotedSource
Omnicom and OMG find academics on notedsource
Unilever research project have used NotedSource to engage academic experts

Connect with researchers and scientists like Marco Demaria on NotedSource to help your company with innovation, research, R&D, L&D, and more.